6,200 The Clorox Company $CLX Shares Bought by Chiron Capital Management LLC

Chiron Capital Management LLC lifted its position in The Clorox Company (NYSE:CLX – Free Report) by 177.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 9,701 shares of the company’s stock after buying an additional 6,200 shares during the period. Chiron Capital Management LLC’s holdings in Clorox were worth $786,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. Mather Group LLC. boosted its position in shares of Clorox by 8,799.9% during the third quarter. Mather Group LLC. now owns 137,503 shares of the company’s stock valued at $11,139,000 after buying an additional 135,958 shares during the last quarter. Godsey & Gibb Inc. grew its stake in shares of Clorox by 30.7% in the third quarter. Godsey & Gibb Inc. now owns 1,627 shares of the company’s stock worth $141,000 after acquiring an additional 382 shares during the period. Krilogy Financial LLC bought a new stake in shares of Clorox in the third quarter worth approximately $867,000. JBGlobal.com LLC purchased a new position in shares of Clorox during the third quarter valued at approximately $443,000. Finally, NorthCrest Asset Manangement LLC raised its holdings in shares of Clorox by 198.7% during the third quarter. NorthCrest Asset Manangement LLC now owns 10,686 shares of the company’s stock valued at $866,000 after purchasing an additional 7,108 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of CLX traded up $0.90 on Thursday, reaching $85.87. The company’s stock had a trading volume of 1,670,957 shares, compared to its average volume of 2,641,282. The stock’s 50 day simple moving average is $93.03 and its two-hundred day simple moving average is $95.46. The company has a debt-to-equity ratio of 15.80, a current ratio of 0.66 and a quick ratio of 0.38. The stock has a market capitalization of $10.38 billion, a P/E ratio of 17.87, a PEG ratio of 2.66 and a beta of 0.59. The Clorox Company has a 12-month low of $79.12 and a 12-month high of $128.90.

Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Monday, August 3rd. The company reported $1.66 EPS for the quarter, beating analysts’ consensus estimates of $1.64 by $0.02. The business had revenue of $1.95 billion during the quarter, compared to analysts’ expectations of $1.91 billion. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The firm’s revenue was down 2.0% on a year-over-year basis. During the same period in the prior year, the company earned $2.87 earnings per share. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Research analysts forecast that The Clorox Company will post 5.77 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th will be paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 5.8%. The ex-dividend date is Wednesday, October 28th. Clorox’s dividend payout ratio is 103.73%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on CLX shares. Jefferies Financial Group cut shares of Clorox from a “buy” rating to a “hold” rating and dropped their target price for the stock from $125.00 to $98.00 in a report on Tuesday, July 28th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 6th. TD Cowen lowered their price target on Clorox from $85.00 to $80.00 and set a “hold” rating on the stock in a report on Tuesday. Wells Fargo & Company dropped their price target on Clorox from $90.00 to $85.00 and set an “equal weight” rating on the stock in a research note on Monday, October 5th. Finally, Barclays reaffirmed an “underweight” rating and issued a $84.00 price objective on shares of Clorox in a report on Tuesday, August 4th. Twelve research analysts have rated the stock with a Hold rating and four have assigned a Sell rating to the company’s stock. According to MarketBeat, Clorox has an average rating of “Reduce” and an average target price of $94.93.

Check Out Our Latest Report on CLX

About Clorox

(Free Report)

The Clorox Company is a consumer and professional products company that develops, manufactures and markets household cleaning, disinfecting, wellness and personal care products. Its portfolio includes the Clorox bleach and cleaning brands, as well as products sold under brands such as Pine-Sol, Liquid-Plumr, Fresh Step, Scoop Away, Kingsford, Hidden Valley, Burt’s Bees and Brita.

Clorox also offers trash bags, food products, water-filtration systems, charcoal and grilling products, cat litter, and professional cleaning and disinfecting solutions.

Further Reading

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.